EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration

Mahdieh Taheri, Mehrdad Roghani, Reza Sedaghat

Cellular and Molecular Neurobiology · 2024-12 · 44 (1)

DOI: 10.1007/s10571-024-01502-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Neurobiology, online erschienen am 23.10.2024. Verfasst von Mahdieh Taheri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran. Hauptthemen laut MEDLINE: Metformin, Trimethyltin Compounds, Hippocampus, Cognitive Dysfunction. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shahed University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The neurotoxicant trimethyltin (TMT) triggers cognitive impairment and hippocampal neurodegeneration. TMT is a useful research tool for the study of Alzheimer's disease (AD) pathogenesis and treatment. Although the antidiabetic agent metformin has shown promising neuroprotective effects, however, its precise modes of action in neurodegenerative disorders need to be further elucidated. In this study, we investigated whether metformin can mitigate TMT cognition impairment and hippocampal neurodegeneration. To induce an AD-like phenotype, TMT was injected i.p. (8 mg/kg) and metformin was administered daily p.o. for 3 weeks at 200 mg/kg. Our results showed that metformin administration to the TMT group mitigated learning and memory impairment in Barnes maze, novel object recognition (NOR) task, and Y maze, attenuated hippocampal oxidative, inflammatory, and cell death/pyroptotic factors, and also reversed neurodegeneration-related proteins such as presenilin 1 and p-Tau. Hippocampal level of AMP-activated protein kinase (AMPK) as a key regulator of energy homeostasis was also improved following metformin treatment. Additionally, metformin reduced hippocampal acetylcholinesterase (AChE) activity, glial fibrillary acidic protein (GFAP)-positive reactivity, and prevented the loss of CA1 pyramidal neurons. This study showed that metformin mitigated TMT-induced neurodegeneration and this may pave the way to develop new therapeutics to combat against cognitive deficits under neurotoxic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminTrimethyltin CompoundsHippocampusCognitive DysfunctionAnimalsMaleNerve DegenerationMaze LearningNeurodegenerative DiseasesOxidative StressNeuroprotective Agents

Stichwörter der Autor:innen

AMP-activated protein kinaseAlzheimer’sMetforminNeurodegenerationNeuroprotectionTrimethyltin

Substanzen

MetformintrimethyltinTrimethyltin CompoundsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
  • Neurophysiology Research Center, Shahed University, Tehran, Iran. mroghani@shahed.ac.ir.
  • Department of Pathology, School of Medicine, Shahed University, Tehran, Iran.

Förderung

  • Shahed University

Zitieren

APA

Taheri, M., Roghani, M., & Sedaghat, R. (2024). Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration. Cellular and Molecular Neurobiology, 44(1). https://doi.org/10.1007/s10571-024-01502-4

Vancouver

Taheri M, Roghani M, Sedaghat R. Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration. Cellular and Molecular Neurobiology. 2024;44(1). doi:10.1007/s10571-024-01502-4

BibTeX
@article{Taheri2024,
  author = {Taheri, Mahdieh and Roghani, Mehrdad and Sedaghat, Reza},
  title = {Metformin Mitigates Trimethyltin-Induced Cognition Impairment and Hippocampal Neurodegeneration},
  journal = {Cellular and Molecular Neurobiology},
  year = {2024},
  volume = {44},
  number = {1},
  doi = {10.1007/s10571-024-01502-4}
}
Kostenlos starten →